Janone Inc. (NASDAQ:ALTS) Short Interest Update
by Tristan Rich · The Markets DailyJanone Inc. (NASDAQ:ALTS – Get Free Report) was the target of a significant growth in short interest in December. As of December 15th, there was short interest totalling 126,700 shares, a growth of 57.0% from the November 30th total of 80,700 shares. Based on an average daily volume of 175,400 shares, the short-interest ratio is currently 0.7 days. Currently, 1.0% of the shares of the stock are short sold.
Janone Trading Up 2.8 %
ALTS stock opened at $4.45 on Monday. Janone has a 12-month low of $0.50 and a 12-month high of $5.26. The business has a 50-day moving average price of $2.86. The company has a debt-to-equity ratio of 1.96, a quick ratio of 0.75 and a current ratio of 0.75.
Janone Company Profile
JanOne Inc, a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology.
Further Reading
- Five stocks we like better than Janone
- What to Know About Investing in Penny Stocks
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- Stock Sentiment Analysis: How it Works
- These 3 Quirky ETFs May Be Strong Plays in 2025
- What Are Dividend Contenders? Investing in Dividend Contenders
- Buffett Takes the Bait; Berkshire Buys More Oxy in December